Bridgefront Capital, LLC Gossamer Bio, Inc. Transaction History

Bridgefront Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$5.97 - $9.97 $76,117 - $127,117	-12,750 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$8.44 - $12.49 $107,610 - $159,247	12,750 New	12,750 $111,000
Q2 2021 Aug 12, 2021	SELL	$8.0 - $9.75 $109,376 - $133,302	-13,672 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$8.63 - $10.94 $44,151 - $55,969	-5,116 Reduced 27.23%	13,672 $126,000
Q4 2020 Feb 12, 2021	BUY	$8.3 - $13.59 $155,940 - $255,328	18,788 New	18,788 $182,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $65.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.